Patent Assignment
Reel/Frame 060466/0302
Assignment of Assignor's Interest
Recorded: 2022-07-08
Pages: 4
Assignors
SONG, COLETTE
Executed: 2018-06-25
SCHOOR, OLIVER
Executed: 2018-06-21
FRITSCHE, JENS
Executed: 2018-06-06
WEINSCHENK, TONI
Executed: 2018-06-21
SINGH, HARPREET
Executed: 2018-06-20
Assignee
IMMATICS BIOTECHNOLOGIES GMBH
PAUL-EHRLICH-STR. 15, TUEBINGEN, 72076, GERMANY
Covered Properties
(4)
Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Application:
17/860,803 →
Publication:
US 2022/0363729
Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers